Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Sinobiomed Scores $1.2 Million Grant for Malaria Vaccine

publication date: Jan 8, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinobiomed announced its China subsidiary received a government subsidy of 9 million RMB ($1.24 million) to continue development of its malaria vaccine. According to Sinobiomed, the grant is the largest ever bestowed on a China biopharma. Sinobiomed’s 82% owned subsidiary, Shanghai Wanxing Bio-pharmaceuticals Co. Ltd., is developing the vaccine in partnership with the Second Military Medical University. We look at the company, its finances and pipeline.  More details...

Stock Symbol: (OTCBB: SOBM)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners